Gsk Share Discussion Threads

[tradermichael] 29/1/2019 16:39

Yeah, I made and lost a fortune on Scoot.

[zicopele] 29/1/2019 16:21

Crikey...Energis is a name from the past.

Anyone remember the shill who used to shamelessly pump Sopheon?

Those companies went pop in 2001. Scoot.com.is another beauty.

[abdullla] 29/1/2019 16:04

Abdullla woz with TMF in the late sixties,these were the times of the disgraced Baltimore,Marconi and Energis all now are RIP!

[dr biotech] 29/1/2019 15:40

Long since given up with TMF Their articles are anodyne and generic - its a shame as back in the early days they used to offer some insight and the tips actually did quite well. I did have a few conversations with one of the better authors too.

[alphorn] 29/1/2019 14:56

Stupid article - the GSK network of local subsidiaries will ensure minimal impact of any loss of sales on the Continent for currently approved products.

[zicopele] 29/1/2019 13:59

TMF is run by shysters. One says buy on a share and his colleague advises sell.

[tradermichael] 29/1/2019 13:17

A couple of snippets from TMF:

See the recent relation of the share price to results announcements. The price has fallen between 1% and 3.5% on three of the previous four results days in the past year, but has recovered quickly thereafter.


As far as Brexit,less than 30% of the companies’ revenues came from Europe in the last quarter, with the rest coming from the US and other international markets, helping to protect it from excessive exposure to a possibly-weaker UK or EU economy.

[montyhedge] 29/1/2019 12:59

Our next quarterly dividend soon is 23p, dividend on the doormat every 13 weeks, I love GSK, lol.

[zicopele] 29/1/2019 12:54

Forward guidance not good.

[montyhedge] 29/1/2019 12:52

They beat on earnings, beat on sales, investors always want more, lol.

[zicopele] 29/1/2019 12:50

PFE is down in the premarket

[montyhedge] 29/1/2019 11:49

Good figures and they beat analyst forecasts, just out from Pfzier bodes well for the sector.

[fuji99] 29/1/2019 09:05

There will probably be a sector rotation and IMO the bio/pharmas turn has arrived as they lost a lot in just less than 2 weeks - Reference to GSK and AZN in particular.
This is following a strong run by oilers and miners in particular.
Defensive stocks will follow for a nice run.

[montyhedge] 29/1/2019 08:50

Nice problem to have demand far outweighed supply.

[montyhedge] 29/1/2019 08:49

Hopefully the Shingles vac supplies gettig better, already blockbuster status. Demand is incredible in the US.GSK a victim of their own success.I think it will be a double blockbuster vac.

[tradermichael] 29/1/2019 08:15

Analysts expect GlaxoSmithKline plc (NYSE:GSK) to report $0.70 EPS on February, 6.They anticipate $0.02 EPS change or 2.78 % from last quarter’s $0.72 EPS. GSK’s profit would be $1.70 billion giving it 13.73 P/E if the $0.70 EPS is correct. After having $0.83 EPS previously, GlaxoSmithKline plc’s analysts see -15.66 % EPS growth. The stock increased 0.08% or $0.03 during the last trading session, reaching $38.45. About 1.68M shares traded. GlaxoSmithKline plc (NYSE:GSK) has risen 8.15% since January 28, 2018 and is uptrending. It has outperformed by 8.15% the S&P500.

[zicopele] 29/1/2019 07:23

ECJ and EU are separate bodies.

[dr biotech] 28/1/2019 22:14

I was only 60/40 in favour of remain. Economically I am 100% remain, but I don’t like a lot of aspects about the EU.

I think if there was a poll about the reasons for leaving, then leaving the single market would have been well below immigration, ECJ and other things. The express/mail and other media ran 10 consecutive days of anti-immigrant headlines before the vote so you can see what they thought the key issues were.

Still I am looking forward to wBecks reasoning on why it’s more important that smaller labs are growing over our bigger pharma’s. The UK biotech sector is littered with corpses of bios that never made it, I invested in enough of them.

[jadeticl3] 28/1/2019 18:23

With a vote 52% Leave 48% Remain it is bound to be very easy to selectively choose folk who say what you wish to hear, which ever side you are on, Dr B! But even on this thread there are views on each side. David Cameron would never have offered the country a choice if he had thought there was any chance of getting a LEAVE result, so like you he must have been persuaded that Remain was a certainty.

[zicopele] 28/1/2019 16:00

Cheap and getting cheaper

[dr biotech] 28/1/2019 13:24

50m a year ongoing cost. Perhaps not “material̶1; but not insignificant.

900 welll paid jobs lost to Amsterdam.

There aren’t going to be any winners in the life science industries. Current useless advice is “find alternative markets”. Any decent business is already looking at all the markets they can.

Why is it more important that smaller companies grow? They are mostly just contract labs that lack innovation and are incapable of getting drugs through the regulation process. Size is important. The smaller labs that I’ve been in have loads of EU staff that will have to go home or won’t be replaced. To say they are more important is just a puff comment from someone who hasn’t got the slightest clue about the industry.